Citation Context

...all patients that developed Ab-mediated PRCA following treatment with multiple ESAs, including another epoetin-a (Epogen/Procrit, Amgen Inc., Thousand Oaks, CA/Johnson & Johnson, New Brunswick, NJ) =-=[12]-=- or epoetin-b (NeoRecormon, Roche Pharmaceuticals, Mannheim, Germany) [13], were exposed to Eprex at some point during the course of their treatment. Prevalence and regional distribution of cases Si...